<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="1 diabetes mellitus, to analyze the clinical characteristics of the" exact="infection" post="and to propose clinical practice recommendations from the Italian"/>
 <result pre="type 1 diabetes mellitus management during COVID-19 pandemic. Results COVID-19" exact="infection" post="in pediatric patients seems to be clinically less severe"/>
 <result pre="is currently no evidence suggesting a higher risk of COVID-19" exact="infection" post="in children with diabetes than unaffected peers. Besides general"/>
 <result pre="research 1 Introduction In December 2019 a new RNA betacoronavirus" exact="infection" post="emerged in Wuhan, China [1]. It has been recognized"/>
 <result pre="the end of January 2020, the WHO named this betacoronavirus" exact="infection" post="COVID-19 and defined it as a global epidemic communicable"/>
 <result pre="of affected individuals [4]. The clinical features of the COVID-19" exact="infection" post="vary from being asymptomatic to fever, dry cough and"/>
 <result pre="Median age of infected individuals is in 50s, with a" exact="prevalence" post="of male gender [4]. Infected adult patients who developed"/>
 <result pre="was performed. 3 Results 3.1 COVID-19 in pediatric patients COVID-19" exact="infection" post="in pediatric patients seems to be clinically less severe"/>
 <result pre="1â€&quot;14Â days, up to 24Â days. Children affected by COVID-19" exact="infection" post="are generally asymptomatic increasing the risk of prolonged spreading"/>
 <result pre="In fact, in more than 90% of affected children, the" exact="infection" post="is clinically silent or is characterized by mild to"/>
 <result pre="viral receptors might partially explain the relative resistance to COVID-19" exact="infection" post="[15]. Recently the Coronavirus Infection in Pediatric Emergency Departments"/>
 <result pre="and underline the importance of considering infectious diseases prompt diagnosis," exact="treatment" post="and, when available, prevention as goal for good management"/>
 <result pre="vaccinations mandatory for patients, especially for seasonal influenza and pneumococcal" exact="infection" post="[35]. Despite several evidence suggests the importance of vaccination"/>
 <result pre="not report an increased risk of hospitalization due to H1N1" exact="infection" post="in pediatric patients with type 1 diabetes [43]. 3.3"/>
 <result pre="with diabetes are included in high risk group for COVID-19" exact="infection" post="with high mortality and morbidity rate. Diabetes mellitus and"/>
 <result pre="with high mortality and morbidity rate. Diabetes mellitus and COVID-19" exact="infection" post="might share more links than expected. Both diseases represent"/>
 <result pre="control with a negative effect on the recovery, also COVID-19" exact="infection" post="may generate a vicious circle that would be detrimental"/>
 <result pre="dysregulation of metabolic control, even if insulin requirement increased after" exact="infection" post="[46]. Worsening of metabolic control affects severity of pneumonia,"/>
 <result pre="COVID-19 infected Italian patients, it has been reported that the" exact="prevalence" post="of pre-existing diabetes was 8.9%, and the ratio of"/>
 <result pre="the ratio of diabetes in patients who died for COVID-19" exact="infection" post="as compared to general population was 1.75 [50]. The"/>
 <result pre="rate that has been observed globally [51]. At present, COVID-19" exact="infection" post="in children and adolescents with type 1 diabetes is"/>
 <result pre="and mortality. Young patients with type 1 diabetes and COVID-19" exact="infection" post="usually donâ€™t need hospitalization, and careful management of glycometabolic"/>
 <result pre="receptors in the endocrine pancreas raises the question if COVID-19" exact="infection" post="is a risk factor for development of dysglycemia. A"/>
 <result pre="the severity of lung inflammation [53]. As for H1N1 viral" exact="infection" post="as possible risk factor for diabetes, it has been"/>
 <result pre="mellitus [54]. At present, there is no association between COVID-19" exact="infection" post="and the increased risk of type 1 diabetes: future"/>
 <result pre="better define the role of COVID-19 and autoimmunity. The COVID-19" exact="infection" post="seems to be unusual among patients with type 1"/>
 <result pre="severe ketoacidosis in new-onset type 1 diabetes due to delayed" exact="diagnosis" post="- because of fear of contracting COVID-19 in a"/>
 <result pre="data extracted from studies looking at clinical characteristics of COVID-19" exact="infection" post="and its impact in patients affected by diabetes mellitus."/>
 <result pre="patients with diabetes. Diabetic patients have an increased risk of" exact="infection" post="with SARS-CoV-2. Comorbidities and older age worsen the prognosis."/>
 <result pre="results of a meta-analysis and of local data, showing the" exact="prevalence" post="of diabetes among adults with COVID-19 Diabetes does not"/>
 <result pre="with COVID-19 Diabetes does not increase the risk of SARS-CoV-2" exact="infection" post="but can worsen the outcome of COVID-19. The rate"/>
 <result pre="1 diabetes particularly during COVID-19 pandemia 3.4 Adaptation of standard-of-care" exact="treatment" post="regimens Several pediatric diabetes centers have developed and implemented"/>
 <result pre="management without close person-to-person contact, thus minimizing the risk of" exact="infection" post="and of metabolic decompensation [57]. Benefit of telemedicine included"/>
 <result pre="On the other hand, promotion of physical exercise even during" exact="quarantine" post="was followed by an improvement of metabolic control [60]."/>
 <result pre="emotional state in children, adolescents, and their caregivers. Intensive insulin" exact="treatment" post="and new technological devices require patients and family engagement"/>
 <result pre="were exposed and the evidence of person-to-person transmission of COVID-19" exact="infection" post="led to the social isolation of patients. Special attention"/>
 <result pre="of person-to-person transmission of COVID-19 infection led to the social" exact="isolation" post="of patients. Special attention and efforts to protect or"/>
 <result pre="infected, or infecting parents and relatives [61]. Even if COVID-19" exact="infection" post="in young patients with type 1 diabetes has been"/>
 <result pre="and Adolescents Diabetes (ISPAD) must be followed, together with specific" exact="treatment" post="for the infection [64]. In case of hospitalization, a"/>
 <result pre="(ISPAD) must be followed, together with specific treatment for the" exact="infection" post="[64]. In case of hospitalization, a multidisciplinary management of"/>
 <result pre="drugs, oral agents may need to be stopped, and insulin" exact="treatment" post="considered for glucose control when hospitalized [65]. COVID-19 outbreak"/>
 <result pre="national real-data on the effects of lockdown and 2020Â year" exact="infection" post="rate on the metabolic and psychological outcomes of patients"/>
 <result pre="1 diabetes 2. Determine the impact of the time of" exact="infection" post="on weight, exercise activity and treatment regimens 3. Develop"/>
 <result pre="of the time of infection on weight, exercise activity and" exact="treatment" post="regimens 3. Develop an epidemiological model to estimate the"/>
 <result pre="type 1 diabetes as well as the impact of the" exact="infection" post="environment into the development of type 2 diabetes 4."/>
 <result pre="in pregnant woman with long-term effects on glucose metabolism and" exact="prevalence" post="of diabetes mellitus. 8 Conclusions (Sharing experience) There is"/>
 <result pre="is currently no evidence suggesting a higher risk of COVID-19" exact="infection" post="in children with diabetes than in unaffected peers. In"/>
 <result pre="in children and adolescents. Despite the risk that the COVID-19" exact="infection" post="may develop into a more severe form seems to"/>
 <result pre="situation report. March 26, 2020. [in Italian] https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_26-marzo202020.pdf. 10WeiM.YuanJ.LiuY.FuT.YuX.ZhangZ.J.Novel coronavirus" exact="infection" post="in hospitalized infants under 1 year of age in"/>
 <result pre="adolescents with type 1 diabetes mellitusClin Case Rep3201563864210.1002/ccr3.26726273460 30BazmamounH.RafeeyM.NikipuoriM.GhergherehchiR.Helicobacer pylori" exact="infection" post="in children with type 1 diabetes: a case control"/>
 <result pre="1 diabetes: a case control studyJHRS1620166871 31ZubairK.U.ShahA.H.FawwadA.SabirR.ButtA.Frequency of urinary tract" exact="infection" post="and antibiotic sensitivity of uropathogens in patients with diabetesPak"/>
 <result pre="damages islets and causes acute diabetesActa Diabetol47201019319910.1007/s00592-009-0109-419333547 53BavishiC.MaddoxT.M.MesserliF.H.Coronavirus disease (COVID-19)" exact="infection" post="and renin angiotensin system blockersJAMA Cardiol202010.1001/jamacardio.2020.1282 54CapuaI.MercalliA.Romero-TejedaA.PizzutoM.S.KasloffS.SordiV.Study of 2009"/>
 <result pre="possible causative agent of diabetesJ Clin Endocrinol Metab10320184343435610.1210/jc.2018-0086230203067 55TattiP.TonoloG.ZanfardinoA.IafuscoD.The CoV-19" exact="infection" post="appears to be unusual among patients with type 1"/>
 <result pre="Therap226202010.1089/dia.2020.0206 60TorneseG.CeconiV.MonastaL.CarlettiC.FaleschiniE.BarbiE.Glycemic control in type 1 diabetes mellitus during covid-19" exact="quarantine" post="and the role of in-home physical activityDiab Technol Therap226202010.1089/dia.2020.0169"/>
</results>
